LUGPA 2023 Enduring CME Program: Turning Impossible to Possible: Solutions to Drive High Quality Care-LUGPA 2023 CME Program Part 1

Video Transcription

Video Summary

The 2023 LUGPA CME program, co-chaired by Dr. Jason Haffron and Dr. Gordon Brown, focuses on equipping urologists with practical solutions to enhance the quality of urological care. This comprehensive program covers new technologies, care pathways, and innovations critical for improving practice. A key highlight was a session on successful bladder cancer programs moderated by Dr. Tom Jayram, where speakers discussed current advancements and challenges in bladder cancer management, including the critical role of transurethral resection and the challenges posed by the BCG shortage. Various treatment options for BCG-unresponsive disease such as novel therapies and clinical trials, including I.O. therapies and combination treatments, were discussed. The panel emphasized the importance of centralized care and the potential of new diagnostic tools and imaging techniques. Moreover, the necessity of having a bladder cancer care navigator and the implications of immune-related adverse events from I.O. therapies were addressed. The program also acknowledged the role of clinical trials in advancing treatment options, encouraging urologists to adapt to new modalities and to collaborate with other specialists to manage disease complexities effectively.

Keywords

urological care

bladder cancer

BCG shortage

transurethral resection

I.O. therapies

clinical trials

diagnostic tools

care pathways